Friday, May 20, 2016

Roche breast cancer drug Perjeta rejected by NICE

… Roche's (ROG.S) breast cancer drug Perjeta, or pertuzumab, has … drug Herceptin, or trastuzumab, before breast cancer surgery to shrink the cancer …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)